Synergies for Cancer Treatments

Pages

  • Home
  • Synergies
  • Drug Repurposing
  • Theory
  • Ammonia
  • TNBC
  • GBM
  • Herbs
  • Reading list
  • Spreadsheet
  • Forum
  • FAQ
  • Terms

Pages

  • Cellular respiration
  • Warburg Effect
  • Urea Cycle
  • Bohr Effect
  • Cell signalling
  • p53 pathway
  • Cancer and Food
  • 100 Natural Substances
  • Safe Use

Hericium Erinaceus

References & Resources
Hericium Erinaceus


  • (2014) Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers
  • (2013) Hericium erinaceus (Lion's Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-tansplanted mice.
  • (2011) Composition and Mechanism of Antitumor Effects of Hericium erinaceus Mushroom Extracts in Tumor-Bearing Mice
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Home
Subscribe to: Posts (Atom)
  • Drug Repurposing Strategies in Oncology
    Drug Repurposing Drug repurposing involves using existing drugs for new therapeutic purposes,  but it remains an experimental approach. Alwa...
  • Theory of Cancer
    The prevalent understanding of cancer progression, known as the driver mutation or somatic mutation theory, asserts that cancer arises when ...
  • Synergistic Anticancer Effects of Diclofenac and Metformin
    Repurposing non-oncology drugs for cancer treatment has become an area of increasing interest. In particular, combinations of well-known pha...
  • Fasting and Silibinin: A Synergistic Approach to Tumor Suppression
    Fasting has long been recognized as a natural strategy for enhancing health, with numerous studies demonstrating its benefits for inhibiting...
  • Itraconazole as a Promising Anti-Cancer Agent: Insights from Recent Studies
    Itraconazole, a widely used antifungal medication, has emerged as a potential repurposed drug for cancer treatment. Beyond its antifungal pr...

Popular Posts

  • Drug Repurposing Strategies in Oncology
    Drug Repurposing Drug repurposing involves using existing drugs for new therapeutic purposes,  but it remains an experimental approach. Alwa...
  • Fasting and Silibinin: A Synergistic Approach to Tumor Suppression
    Fasting has long been recognized as a natural strategy for enhancing health, with numerous studies demonstrating its benefits for inhibiting...
  • Itraconazole as a Promising Anti-Cancer Agent: Insights from Recent Studies
    Itraconazole, a widely used antifungal medication, has emerged as a potential repurposed drug for cancer treatment. Beyond its antifungal pr...
  • Discovery of Stem-Like CD4 T Cells
    Researchers at Emory University's Winship Cancer Institute have uncovered a previously unknown immune cell type, a  stem-like CD4 T cell...
  • Repurposing Phenylbutyrate: versatile anticancer agent
    Phenylbutyrate (PB), a short-chain fatty acid derivative, is primarily recognized as an ammonia scavenger and histone deacetylase inhibitor ...
  • Combination of RAS(ON) G12C-selective inhibitors with SHP2 inhibitors to sensitize tumours to immune checkpoint blockade
    Lung cancer driven by KRAS mutations, particularly the G12C variant, remains a significant challenge in non-small cell lung cancer (NSCLC) t...
  • Enhanced Cancer Immunotherapy by Targeting Monoamine Oxidase A (MAO-A)
    Monoamine oxidase A (MAO-A), an enzyme historically studied for its role in neurotransmitter metabolism, has emerged as a promising target i...
  • Repurposing metformin for cancer treatment
    Across various cancer types and contexts, metformin has demonstrated promising anti-tumor mechanisms that include modulating cellular energy...
  • Synergistic Anticancer Effects of Diclofenac and Metformin
    Repurposing non-oncology drugs for cancer treatment has become an area of increasing interest. In particular, combinations of well-known pha...
  • Repurposing Niclosamide: A Multi-Targeted Approach to Cancer Therapy Through Metabolic Disruption, Immune Modulation, and Oncogenic Pathway Inhibition
    Niclosamide, approved initially as an anthelmintic, has garnered significant attention in oncology for its anticancer potential. The reposit...

Featured Post

Metastasis

About 90% of deaths from cancer are a result of metastasis. This article discusses Dr. Dana Pe'er's research on cellular plasticit...

Nature Reviews Cancer

Loading...

Translate

Blog Archive

Subscribe To RSS feed

Posts
Atom
Posts
All Comments
Atom
All Comments

Total Pageviews

Powered By Blogger
© synergiesforcancertreatments.blogspot.com - A different approach to cancer treatment . Powered by Blogger.